The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Signaling Mechanisms of HIV-1 Tat-Induced Alterations of Claudin-5 Expression in Brain Endothelial Cells
Abstract
Exposure of brain microvascular endothelial cells (BMEC) to human immunodeficiency virus-1 (HIV-1) Tat protein can decrease expression and change distribution of tight junction proteins, including claudin-5. Owing to the importance of claudin-5 in maintaining the blood–brain barrier (BBB) integrity, the present study focused on the regulatory mechanisms of Tat-induced alterations of claudin-5 mRNA and protein levels. Real-time reverse-transcription-polymerase chain reaction revealed that claudin-5 mRNA was markedly diminished in BMEC exposed to Tat. However, U0126 (an inhibitor of mitogen-activated protein kinase kinase1/2, MEK1/2) protected against this effect. In addition, inhibition of the vascular endothelial growth factor receptor type 2 (VEGFR-2) by SU1498, phosphatidylinositol-3 kinase (PI-3 K) by LY294002, nuclear factor-κB (NF-κB) by peptide SN50, and intracellular calcium by BAPTA/AM partially prevented Tat-mediated alterations in claudin-5 protein levels and immunoreactivity patterns. In contrast, inhibition of protein kinase C did not affect claudin-5 expression in Tat-treated cells. The present findings indicate that activation of VEGFR-2 and multiple redox-regulated signal transduction pathways are involved in Tat-induced alterations of claudin-5 expression. Because claudins constitute the major backbone of tight junctions, the present data are relevant to the disturbances of the BBB in the course of HIV-1 infection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activation of ERK1/2 results in increased ZO-1 degradation during traumatic brain injury (51), decreased ZO-1 and claudin 5 expression in brain endothelium during HIV infection (52,53), and reduced occludin and claudin 5 expression in BBB endothelium during ischemic stroke (54).”
From Bacterial induction of Snail1 contributes to blood-brain barrier disruption (2015) · cites this paper as [52]
Citations
Cites
Kyriakis, J. M., & Avruch, J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.807 · Cited by 3,400
Furuse, M., Fujita, K., Hiiragi, T., Fujimoto, K., & Tsukita, S. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.7.1539 · Cited by 2,100
Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice
Nitta, T., Hata, M., Gotoh, S., Seo, Y., Sasaki, H., Hashimoto, N., Furuse, M., & Tsukita, S. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302070 · Cited by 1,917
Morita, K., Sasaki, H., Furuse, M., & Tsukita, S. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.1.185 · Cited by 867
Molecular physiology and pathophysiology of tight junctions in the blood–brain barrier
Huber, J. D., Egleton, R. D., & Davis, T. P. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02004-x · Cited by 790
Ikenouchi, J., Matsuda, M., Furuse, M., & Tsukita, S. (2003) · Journal of Cell Science · doi:10.1242/jcs.00389 · Cited by 678
Transforming Growth Factor β-1 Induces Snail Transcription Factor in Epithelial Cell Lines
Peinado, H., Quintanilla, M., & Cano, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211304200 · Cited by 642
Liebner, S., Fischmann, A., Rascher, G., Duffner, F., Grote, E.-H., Kalbacher, H., & Wolburg, H. (2000) · Acta Neuropathologica · doi:10.1007/s004010000180 · Cited by 490
Chang, H. C., Samaniego, F., Nair, B. C., Buonaguro, L., & Ensoli, B. (1997) · AIDS · doi:10.1097/00002030-199712000-00006 · Cited by 441
Drug and Gene Delivery to the Brain
Pardridge, W. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)01054-1 · Cited by 411
Flagged first, then by citations
Research works printed but not linked: 5
- Barillari G, 1999, Blood, 94, 663
- Deli MA, 1997, Drug transport across the blood–brain barrier: in vivo and in vitro techniques, 23
- Rhodes RH, 1991, Pathol Annu, 26, 247
- Singer EJ, 1994, J Acquir Immune Defic Syndr, 7, 265
- Wu DT, 2000, J Neurovirol, 6, S82
Cited by
Sorted by citations
Items 101–121 of 121
Wu, M.-C., Wang, E. Y., & Lai, T. W. (2023) · PLoS ONE · doi:10.1371/journal.pone.0292681 · Cited by 15
How Much Does HIV Positivity Affect the Presence of Oral HPV? A Molecular Epidemiology Survey
Visalli, G., Pietro, A. D., Currò, M., Ciarello, M. P., D’Andrea, F., Nunnari, G., Pellicanò, G. F., & Facciolà, A. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18178999 · Cited by 16
Pitfalls of Antiretroviral Therapy: Current Status and Long-Term CNS Toxicity
Rudd, H., & Toborek, M. J. (2022) · Biomolecules · doi:10.3390/biom12070894 · Cited by 18
Self-citationZhang, Y., Chen, H., Zhang, H.-X., Wang, K., Su, J., Chen, Y., Wang, X., Fu, Z.-F., & Cui, M. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.894356 · Cited by 14
Cirino, T. J., Alleyne, A. R., Duarte, V., Figueroa, A. M., Simons, C. A., Anceaume, E. M., Kendrick, J., Wallman, O. M., Eans, S. O., Stacy, H. M., et al. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-09985-4 · Cited by 13
Zhao, H., Zhang, Q., Xue, Y., Chen, X., & Haun, R. S. (2011) · Experimental Brain Research · doi:10.1007/s00221-011-2702-3 · Cited by 13
Annadurai, N., & Kanmogne, G. D. (2024) · Cells · doi:10.3390/cells13171415 · Cited by 12
Khan, I. A., Worrad, A. H., Singh, M. V., Maggirwar, S. B., & Singh, V. B. (2022) · Journal of NeuroVirology · doi:10.1007/s13365-022-01061-8 · Cited by 12
Rademeyer, K. M., Nass, S. R., Jones, A. M., Ohene‐Nyako, M., Hauser, K. F., & McRae, M. (2024) · Journal of NeuroVirology · doi:10.1007/s13365-023-01186-4 · Cited by 12
Laloux, L., Polet, M., & Schneider, Y. (2017) · Wiley eBooks · doi:10.1002/9783527697724.ch18 · Cited by 6
Opinion: Inhibition of Blood-Brain Barrier Repair as a Mechanism in HIV-1 Disease
Maubert, M. E., Wigdahl, B. L., & Nonnemacher, M. R. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00228 · Cited by 6
Disruption of the Blood-Brain Barrier During Neuroinflammatory and Neuroinfectious Diseases
Salimi, H., & Klein, R. S. (2024) · Springer eBooks · doi:10.1007/978-3-031-60006-7_7 · Cited by 4
Saro, A., Gao, Z., Kambey, P. A., Li, M., & Huang, J. (2022) · Viruses · doi:10.3390/v14122793 · Cited by 3
Nanotherapeutic Approach to Targeting HIV-1 in the CNS
Mahajan, S. D., Aalinkeel, R., Reynolds, J. L., Nair, B. B., Mammen, M. J., Dai, L., Prasad, P. N., & Schwartz, S. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801317-5.00015-3 · Cited by 2
Testis Is a Sanctuary Site for HIV-1
Chung, N. P. Y., & Cheng, C. Y. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-82990-1_19 · Cited by 1
Interactions between the immune and nervous systems
Kilpatrick, T. J., Ransohoff, R. M., & Wesselingh, S. L. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9781139195805.002 · Cited by 1
Tyagi, P., & Tyagi, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99744-7.00007-9 · Cited by 1
Buch, S. J., & Yao, H. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-382032-7.10057-8 · Cited by 1
Negotiating the brain barriers:
Engelhardt, B. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9781139195805.005
Quantification of Cell Penetrating Peptide Uptake By Fluorescent Techniques
Staley, B. P. (2012) · Research Explorer (The University of Manchester)
ASTROCYTE-ENDOTHELIAL INTERACTIONS: IMPLICATIONS FOR HIV-ASSOCIATED NEUROCOGNITIVE DISORDER
Bethel-Brown, C. S. (2011) · KU ScholarWorks (University of Kansas)
Metadata
- Authors
- András, I. E., Pu, H., Tian, J., Deli, M. A., Nath, A., Hennig, B., & Toborek, M.
- Affiliations
- Department of Surgery, University of Kentucky, Lexington, Kentucky, USA
- University of Kentucky (US)
- HUN-REN Szegedi Biológiai Kutatóközpont (HU)
- Johns Hopkins University (US)
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2005-09
- Volume
- 25
- Issue
- 9
- Pages
- 1159-1170
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- OpenAlex
- W1973010584
- Cited by
- 121
- References
- 59
- Citations by year
- 2025: 3 · 2024: 4 · 2023: 5 · 2022: 6 · 2021: 5 · 2020: 8 · 2019: 5 · 2018: 3 · 2017: 6 · 2016: 8 · 2015: 4 · 2014: 7 · 2013: 7 · 2012: 9
- FWCI
- 4.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Cerebral Blood Flow & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r21aa013843-03)
- National Institute on Alcohol Abuse and Alcoholism (AA 013843)
- National Institute of Mental Health (MH 63022, R01MH063022)
- National Institute of Neurological Disorders and Stroke (R01NS039254, NS-39254)
- National Institute of Environmental Health Sciences (P42ES007380)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Keywords
- HIV-1 Tat protein, claudin-5, brain microvascular endothelial cells, blood-brain barrier, tight junction proteins, VEGFR2 signaling, PI3K signaling, NF-κB signaling, MEK1/2, redox signaling, intracellular calcium, protein kinase C, HIV-associated neurocognitive disorders
- MeSH terms
- Animals, Brain Chemistry, Calcium, Cells, Cultured, Chelating Agents, Membrane Proteins, Microscopy, Fluorescence, Genes, ras, RNA, Messenger, Blotting, Western, Signal Transduction, HIV-1, Down-Regulation, Gene Products, tat, NF-kappa B, Rats, Wistar, Reverse Transcriptase Polymerase Chain Reaction, Vascular Endothelial Growth Factor Receptor-2, Endothelial Cells, Rats, tat Gene Products, Human Immunodeficiency Virus, Claudin-5
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review